CLPT vs MSCI · rev $23.0M vs P/E 37, rev $1.72B
Clearpoint Neuro Inc (CLPT) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Clearpoint Neuro Inc (CLPT) is a medical devices company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported CLPT revenue for 2026-06-30 was $23.0M. Net income was -$20.9M. Revenue was up 89.7% from 2026-03-31 to 2026-06-30. CLPT currently screens at market cap $371.0M.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
CLPT currently screens at market cap $371.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the CLPT and MSCI stock pages for the full models.
Not investment advice.